These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1083173)

  • 1. Influence of adrenalectomy, total body x-irradiation and dexamethasone on the amount of CRF-granules and "classical" neurosecretory material in the rat neurohypophysis.
    Schwabedal P; Bock R
    Anat Embryol (Berl); 1975 Dec; 148(3):267-78. PubMed ID: 1083173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of sodium chloride on the amount of CRF-granules and "classical" neurosecretory material (NSM) in the neurohypophysis of bilaterally adrenalectomized rats.
    Schwabedal PE; Partenheimer U; Bock R
    Anat Embryol (Berl); 1976 Sep; 149(3):307-13. PubMed ID: 1086619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural alterations of the paraventriculo-infundibular corticotropin releasing factor (CRF)-immunoreactive neuronal system in long term adrenalectomized rats.
    Liposits Z; Paull WK
    Peptides; 1985; 6(6):1021-36. PubMed ID: 3010254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles.
    Whitnall MH; Mezey E; Gainer H
    Nature; 1985 Sep 19-25; 317(6034):248-50. PubMed ID: 3900740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional difference between "classical" neurosecretory material and vasopressin-like substances of the outer layer of the median eminence.
    Bock R; Detzer K; Leicht E; Röder R
    Cell Tissue Res; 1980; 212(2):257-77. PubMed ID: 7428031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative immunocytochemistry of corticotropin-releasing factor (CRF). Studies on nonbiological models and on hypothalamic tissues of rats after hypophysectomy, adrenalectomy and dexamethasone treatment.
    Schipper J; Werkman TR; Tilders FJ
    Brain Res; 1984 Feb; 293(1):111-8. PubMed ID: 6367890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.
    Hashimoto K; Yunoki S; Kageyama J; Ohno N; Takahara J; Ofuji T
    Neuroendocrinology; 1981 Feb; 32(2):87-91. PubMed ID: 6259547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of vasopressin in the down-regulation of pituitary corticotropin-releasing factor receptors after adrenalectomy.
    Holmes MC; Catt KJ; Aguilera G
    Endocrinology; 1987 Dec; 121(6):2093-8. PubMed ID: 2824180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemical and immunohistochemical properties of the CRF-granules and other "Gomori-positive" substances of the rat.
    Bock R; Salland T; Schwabedal PE
    Histochemistry; 1976 Feb; 46(2):81-105. PubMed ID: 765309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The corticotropin releasing factor (CRF) neurosecretory system in intact, adrenalectomized, and adrenalectomized-dexamethasone treated rats. An immunocytochemical analysis.
    Paull WK; Gibbs FP
    Histochemistry; 1983; 78(3):303-16. PubMed ID: 6350236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.
    Fink G; Robinson IC; Tannahill LA
    J Physiol; 1988 Jul; 401():329-45. PubMed ID: 2845063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin-containing and vasopressin-deficient subpopulations of corticotropin-releasing factor axons are differentially affected by adrenalectomy.
    Whitnall MH; Key S; Gainer H
    Endocrinology; 1987 May; 120(5):2180-2. PubMed ID: 3494595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipsilateral diminution of CRF-granules after unilateral hypothalamic lesions.
    Bock R; Jurna I
    Cell Tissue Res; 1977 Dec; 185(2):215-29. PubMed ID: 304378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bilateral adrenalectomy on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.
    Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K
    Endocrinology; 1983 Sep; 113(3):1182-4. PubMed ID: 6307668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats.
    Jingami H; Matsukura S; Numa S; Imura H
    Endocrinology; 1985 Oct; 117(4):1314-20. PubMed ID: 2992910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration that corticotropin-releasing factor binding to rat peripheral tissues is modulated by glucocorticoid treatment in vivo and in vitro.
    Dave JR; Eskay RL
    Biochem Biophys Res Commun; 1986 Jan; 134(1):255-60. PubMed ID: 3484949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.
    Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K
    Endocrinology; 1984 Mar; 114(3):851-4. PubMed ID: 6321142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical ultrastructural study of hypothalamic neurons containing corticotropin-releasing factor in normal and adrenalectomized rats.
    Alonso G; Siaud P; Assenmacher I
    Neuroscience; 1988 Feb; 24(2):553-65. PubMed ID: 3258967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocinergic neurons in rat hypothalamus. Dexamethasone-reversible increase in their corticotropin-releasing factor-41-like immunoreactivity in response to osmotic stimulation.
    Dohanics J; Kovacs KJ; Makara GB
    Neuroendocrinology; 1990 May; 51(5):515-22. PubMed ID: 2112729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.